Correct Answer:

See The answer in Explanation part below.
Explanation:
Step 1 - Recognise why the suggestion, though understandable, is methodologically incorrect. The lead tester's enthusiasm is understandable - achieving the primary objective undetected is a genuinely strong result - but the suggestion to end active testing three weeks early conflicts directly with TIBER-EU's minimum 12-week active testing guidance, which exists, as covered in the syllabus, for substantive methodological reasons (allowing realistic, patient adversary emulation and providing a genuine, sustained test of detection capability over a realistic timeframe), not merely as an arbitrary box to tick once any single objective is achieved.
Step 2 - Reject the "we've proven the point already" framing. Early achievement of the primary objective does not mean "nothing important is likely to change" - this framing significantly understates the value of the remaining time. As established elsewhere in this syllabus, a well-planned TIBER-EU engagement should have identified secondary, still-plausible attack paths (exactly as this scenario describes, with the cross-border reinsurance data-sharing scenario) precisely so that remaining time can be used productively rather than the exercise simply stopping once one objective is reached.
Step 3 - Do not unilaterally decide to end testing early. As Red Team provider lead contact, you should not agree to end active testing early based on your lead tester's operational preference (however reasonably intentioned, including the genuine desire to free up the team for other work) without this being a decision made transparently with the Control Team and, given TIBER-EU's minimum-duration guidance, very likely requiring at least awareness of the national TIBER Cyber Team, consistent with the syllabus principle that material deviations from framework timing guidance should not be decided informally by the delivery team alone.
Step 4 - Recommend pivoting to the secondary threat actor/attack path for the remaining weeks. The professionally sound recommendation is to use the remaining three mandated weeks productively by pivoting to explore the secondary, still-plausible threat actor and attack path (the cross-border reinsurance data-sharing scenario) that the original plan had specifically reserved time for - this makes full, valuable use of the mandated window, provides Larchmont with meaningfully broader insight beyond the single already-proven objective, and respects the framework's minimum-duration guidance in substance, not just in form.
Step 5 - Address the resourcing tension honestly rather than ignoring it. The lead tester's underlying point about wanting to free up the team for other engagements reflects a genuine resourcing/capacity consideration (echoing the concurrent-engagement management principle discussed elsewhere in this practice set), and this should not simply be dismissed - but the correct response is to raise this transparently with your own firm's resourcing/practice management function as a separate capacity planning conversation, rather than allowing it to unilaterally drive premature conclusion of a live, regulator-relevant engagement that has mandated timing requirements.
Step 6 - Communicate transparently with the Control Team about the strong early result and the plan for the remaining time. You should proactively inform the Control Team of the strong, undetected achievement of the primary objective (itself a significant, positive finding worth flagging promptly, consistent with the reporting domain's guidance on timely communication of significant developments) and explain the plan to use the remaining mandated weeks to explore the secondary, still-plausible scenario - giving the Control Team full visibility and the opportunity to input on or endorse this plan, rather than either silently continuing without explanation or silently stopping early without their knowledge.
Step 7 - Consider whether the strong result also has an earlier learning opportunity, without ending testing.
While full closure/purple-teaming should still occur only at the properly planned end of the Testing phase, you might also confirm with the Control Team whether they wish to be given a preliminary, high-level heads- up about the strength of the primary result now (while continuing testing on the secondary path) - a judgement call to be made collaboratively with the Control Team, balancing their interest in early insight against maintaining full engagement momentum and Blue Team blindness through to the properly planned closure point.
Conclusion: The lead tester's suggestion to end active testing three weeks early should not be accepted; the mandated minimum testing window should be used productively by pivoting to the secondary, still-plausible threat actor and attack path the original plan reserved time for, with this plan communicated transparently to the Control Team; and any genuine resourcing/capacity tension underlying the tester's suggestion should be addressed separately through the provider's own internal capacity management, not by cutting short a live, framework-governed engagement.
---